Cantor Fitzgerald Reiterates Overweight on Braze, Maintains $38 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 74.6%

Neg 0% Neu 74.6% Pos 0%

Cantor Fitzgerald analyst Matthew Vanvliet reiterates Braze (NASDAQ:BRZE) with a Overweight and maintains $38 price target.